Magnicare Pharma Private Limited
About Magnicare Pharma Private Limited
Data last updated:
Magnicare Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 22 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2014PTC153516. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajan Ramji Jadhav and Rahul Jadhav.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at S.No.11/3 Sai Apartment Flat No. 19 Morya Park Lane No.4 Pimple Gurav, Pune, Maharashtra, India – 411027.
As per the financials filed for FY 2018, the company reported a revenue of ₹1.7 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net loss of ₹40,195 (net margin -23.6%) and EBITDA of -₹34,301 (EBITDA margin -20.1%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Magnicare Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressS.No.11/3 Sai Apartment Flat No. 19 Morya Park Lane No.4 Pimple Gurav, Pune, Maharashtra, India – 411027
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Magnicare Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Magnicare Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Magnicare Pharma Private Limited, buy the company report.
Financials of Magnicare Pharma Private Limited
FY 2018 filings availableMagnicare Pharma Private Limited reported revenue of ₹1.7 Lakh (up 36% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 90% over three years, including 36% growth in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹34,301 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹40,195 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -20.1% | |||
| Net Profit Margin | -23.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Magnicare Pharma Private Limited, buy the company report.
Board of directors of Magnicare Pharma Private Limited
Magnicare Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Jadhav | Additional Director | 15 Feb 2018 | 8 Years 9 Months | Current |
| Rajan Ramji Jadhav | Director | 22 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Magnicare Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxkind Laboratories Private Limited | ₹1.72 Lakh (FY 2024) | 94.0% | Jaunpur, Uttar Pradesh, India | |||
| Genores Biotech Private Limited | ₹1.72 Lakh (FY 2024) | -100.0% | Panvel, Maharashtra, India | |||
| Marksure Pharma Private Limited | ₹1.72 Lakh (FY 2025) | -74.0% | Sambhal, Uttar Pradesh, India | |||
| Citifrag India Private Limited | ₹1.71 Lakh (FY 2025) | -63.0% | Hyderabad, Telangana, India | |||
| Param Herbal Remedies Private Limited | ₹1.71 Lakh (FY 2020) | -71.0% | Punjab, India | |||
| Magnicare Pharma Private Limitedthis company | ₹1.7 Lakh (FY 2018) | -₹40,195 | -23.6% | 36.0% | Pune, Maharashtra, India | |
| Grosswell Health Care Private Limited | ₹1.7 Lakh (FY 2023) | 136.0% | Akbarpur, Uttar Pradesh, India | |||
| Habitus Pharma Private Limited | ₹1.7 Lakh (FY 2025) | Amritsar, Punjab, India | ||||
| Sanbratech Suppliers Private Limited | ₹1.7 Lakh (FY 2020) | Sultanpur, Uttar Pradesh, India | ||||
| Laashreetha Engineers & Consultants Private Limited | ₹1.69 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Dhanbhoomi Agrotech Private Limited | ₹1.69 Lakh (FY 2021) | Pune, Maharashtra, India |
To see the full peer comparison of Magnicare Pharma Private Limited, buy the company report.
Auditor
Magnicare Pharma Private Limited is audited by KEDAR A SABANE for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KEDAR A SABANE | FY 2017 | 162527 |
Shareholding
The shareholding of Magnicare Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Magnicare Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Magnicare Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Magnicare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Magnicare Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Magnicare Pharma Private Limited, buy the company report.
Recent activity
Magnicare Pharma Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Megha Rahul Jadhav ceased to be Director on 15 Feb 2018.
Frequently asked questions
Magnicare Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 22 December 2014 (12+ years old) and is registered under CIN U74900PN2014PTC153516.
Magnicare Pharma has 2 current directors:
- Rahul Jadhav - Additional Director
- Rajan Ramji Jadhav - Director
The latest financial statements of Magnicare Pharma on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
No. Magnicare Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Magnicare Pharma is U74900PN2014PTC153516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Magnicare Pharma was incorporated on 22 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Magnicare Pharma by revenue are Maxkind Laboratories Private Limited, Genores Biotech Private Limited, Marksure Pharma Private Limited, Citifrag India Private Limited, Param Herbal Remedies Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Megha Rahul Jadhav ceased to be Director on 15 Feb 2018. Rahul Jadhav was appointed as Additional Director on 15 Feb 2018. Rajan Ramji Jadhav was appointed as Director on 22 Dec 2014.
The registered office of Magnicare Pharma is at S.No.113 Sai Apartment Flat No. 19 Morya Park Lane No.4 Pimple Gurav, Pune, Maharashtra, India – 411027.
Magnicare Pharma operates in the chemicals industry, in the chemical products segment.
The compliance status of Magnicare Pharma is active non-compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
